Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1Cohance Lifesciences
Methyl 3-((3S)-7-bromo-2-((2-hydroxypropyl)amino)-...
CAS Number : 308243-54-1
End Use API :
End Use API : Remimazolam Besylate
About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our expe...
LOOKING FOR A SUPPLIER?